NUTEX Investments Public Limited Company

BUSE:NUTEX Stock Report

Market Cap: Ft2.0b

NUTEX Investments Past Earnings Performance

Past criteria checks 1/6

NUTEX Investments has been growing earnings at an average annual rate of 80.9%, while the Pharmaceuticals industry saw earnings growing at 10.5% annually. Revenues have been growing at an average rate of 9.9% per year. NUTEX Investments's return on equity is 1.4%, and it has net margins of 15711.5%.

Key information

80.9%

Earnings growth rate

70.5%

EPS growth rate

Pharmaceuticals Industry Growth12.4%
Revenue growth rate9.9%
Return on equity1.4%
Net Margin15,711.5%
Last Earnings Update30 Jun 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How NUTEX Investments makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BUSE:NUTEX Revenue, expenses and earnings (HUF Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 23071210
31 Mar 230101190
31 Dec 220131160
30 Sep 220115150
30 Jun 22099140
31 Mar 22056140
31 Dec 21013130
30 Sep 210-10140
30 Jun 210-32140
31 Mar 210-3160
31 Dec 20026190
30 Sep 20015180
30 Jun 2004180
31 Mar 200-2140
31 Dec 191-8100

Quality Earnings: NUTEX has a high level of non-cash earnings.

Growing Profit Margin: NUTEX's current net profit margins are lower than last year .


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: NUTEX's earnings have grown significantly by 80.9% per year over the past 5 years.

Accelerating Growth: NUTEX's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: NUTEX had negative earnings growth (-28.6%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (2.6%).


Return on Equity

High ROE: NUTEX's Return on Equity (1.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.